We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Elevated Cholesterol Reported in Blood Tests on Children

By LabMedica International staff writers
Posted on 28 Jul 2010
The concentration of low-density lipoprotein (LDL) in the blood is a guide to the health of the individual. More...
Increased LDL cholesterol is indicative of type 2 diabetes and early heart attacks.

The normal value of LDL for children ages 2-19 years is under 130 mg/dL. Serum concentrations of total cholesterol and triglycerides are determined using enzymatic procedures. Children are seldom checked for their cholesterol levels as screening them has until recently not been considered a priority.

In a study, 20,266 fifth-grade children, had blood taken and a lipid panel analysis was performed. The panel included total cholesterol, triglycerides, and LDL and, very-low density lipoprotein (VLDL) serum levels (Abbott, North Chicago, IL, USA). The LDL and VLDL concentration were measured after heparin–calcium precipitation and determined by densitometric (electrophoretic) ratio and cholesterol content of the two lipoproteins.

The study found that among the 11-year-olds who met current cholesterol screening guidelines, 8.3% had LDL cholesterol levels of 130 mg/dL or higher, and 1.2% had LDL cholesterol levels of 160 mg/dL or higher. Among the 11-year-olds who would not have been screened under current guidelines, 9.5% had LDL cholesterol levels of 130 mg/dL or higher and 1.7% had LDL cholesterol levels of 160 mg/dL or higher.

More than 70% of the 20,266 children who were screened would have qualified for routine cholesterol screening, according to current U.S. National Cholesterol Education Program (NCEP; Bethesda, MD, USA) guidelines. But even more surprising was how many children had high cholesterol even though they would not have qualified for routine screening. The study was performed at the West Virginia University, (West Virginia University, Morgantown, WV, USA).

William Neal, MD, professor of pediatrics at West Virginia University, said, "A lot of parents told us they did not even know children had cholesterol, let alone high cholesterol. Just as many children who would not have been screened ended up with severely high cholesterol levels as in the group that did qualify for screening based on family history.” One in three children with dangerously high cholesterol is missed by current screening recommendations. The study was published in July 2010 in Pediatrics.

Related Links:
Abbott
U.S. National Cholesterol Education Program
West Virginia University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Immunofluorescence Analyzer
IFA System
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.